[KLF3 regulates the movement, migration and invasion of breast cancer cells through STAT3]

F Lü1, C Li1, Y Yu1

  • 1Department of Breast Surgery, Henan Provincial People's Hospital, Zhengzhou 450003, China.

Zhonghua Yi Xue Za Zhi
|October 15, 2019
PubMed

Insights

Krüppel-like factor 3 (KLF3) knockdown increases Signal transducer and activator of transcription 3 (STAT3) expression and transcriptional activity in breast cancer cells. KLF3 impacts breast cancer cell movement and invasion, suggesting KLF3 as a potential therapeutic target.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • Signal transducer and activator of transcription 3 (STAT3) is frequently dysregulated in various cancers, including breast cancer.
  • Krüppel-like factor 3 (KLF3) is a transcription factor with known roles in cellular differentiation and development, but its specific function in breast cancer progression remains to be fully elucidated.

Purpose of the Study:

  • To investigate the effect of KLF3 on STAT3 expression in breast cancer cells.
  • To explore the underlying mechanism by which KLF3 influences breast cancer cell migration, invasion, and metastasis.

Main Methods:

  • Western blot, RT-qPCR, and luciferase reporter assays were employed to assess STAT3 expression and transcriptional activity.
  • Chromatin immunoprecipitation (ChIP) was used to determine KLF3 binding to the STAT3 promoter.
  • Cellular assays (scratch, Transwell) and in vivo animal models were utilized to evaluate cell migration, invasion, and metastasis.

Main Results:

  • KLF3 knockdown led to increased STAT3 protein and mRNA levels and enhanced STAT3 transcriptional activity in breast cancer cell lines (MDA-MB-231 and MCF-7).
  • KLF3 directly binds to the promoter region of STAT3.
  • KLF3 knockdown inhibited breast cancer cell movement, migration, and invasion, effects partially reversed by STAT3 silencing. In vivo studies showed KLF3 knockdown promoted tumor metastasis.

Conclusions:

  • KLF3 functions as a negative regulator of STAT3 transcription and activity in breast cancer.
  • KLF3 suppresses breast cancer cell migration, invasion, and metastasis, at least in part, through the modulation of STAT3.
  • KLF3 represents a promising therapeutic target for managing metastatic breast cancer.

Related Concept Videos

Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.2K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K
Cell Migration01:09

Cell Migration

Cell migration, the process by which cells move from one location to another, is essential for the proper development and viability of organisms throughout their life. When cells are not able to migrate properly to their ordained locations, various disorders may occur. For example, disruption in cell migration causes chronic inflammatory diseases such as arthritis.
18.4K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
11.7K